Emergent BioSolutions Inc (NYSE: EBS) stock closed at $11.00 on 11/7/24 after a major increase of 19.6%. Moreover, this advance was accompanied by exceptionally high trading volume at 289% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 14.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Emergent BioSolutions has a good Appreciation Score of 84 and a very high Power Rating of 98, leading to the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment